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Introduction
During development, tissue differentiation relies on the es-
tablishment of specific patterns of gene expression, which is 
achieved by lineage-specific gene activation and silencing in 
multipotent stem cells and their progenies (Slack, 2008; Blan-
pain and Fuchs, 2014). The program of epidermal differentiation 
in mice begins at about embryonic day 9.5 (E9.5) and results 
in the formation of an epidermal barrier by E18.5 (Koster and 
Roop, 2007; Blanpain and Fuchs, 2009). The process of termi-
nal differentiation in epidermal cells is executed by sequential 
changes of gene expression in the keratin type I/II loci, followed 
by the onset of expression of the epidermal differentiation com-
plex genes encoding the essential components of the epidermal 
barrier (Fuchs, 2007). This program is governed by the coordi-
nated involvement of several transcription factors (p63, AP-1, 
Klf4, Arnt, etc.), signaling pathways (Wnt, Bmp, Hedgehog, 
EGF, Notch, FGF, etc.), and epigenetic regulators (DNA/his-
tone-modifying enzymes, Polycomb genes, higher order and 
ATP-dependent chromatin remodelers, and noncoding and 
microRNAs) that control expression of lineage-specific genes 
(Khavari et al., 2010; Botchkarev et al., 2012; Frye and Benitah, 
2012; Perdigoto et al., 2014).
Among these regulatory molecules, the p63 transcription 
factor serves as a master regulator of epidermal development and 
controls expression of a large number of distinct groups of genes 
(Viganò and Mantovani, 2007; Vanbokhoven et al., 2011; Botch-
karev and Flores, 2014; Kouwenhoven et al., 2015). p63 knockout 
(KO) mice fail to form stratified epithelium and express several 
epidermis-specific genes (Mills et al., 1999; Yang et al., 1999). In 
the epidermis, p63 regulates the expression of distinct chroma-
tin-remodeling factors, such as Satb1 and Brg1, which, in turn, 
control the establishment of specific nuclear positioning and con-
formation of the epidermal differentiation complex locus required 
for full activation of keratinocyte (KC)-specific genes during ter-
minal differentiation (Fessing et al., 2011; Mardaryev et al., 2014).
Epigenetic regulators exhibit both activating and repres-
sive effects on chromatin in KCs: the histone demethylase 
Jmjd3, ATP-dependent chromatin remodeler Brg1, and genome 
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organizer Satb1 promote terminal KC differentiation, whereas 
the DNA methyltransferase DNMT1, histone deacetylases 
HDAC1/2, and Polycomb components Bmi1 and Ezh1/2 stim-
ulate proliferation of the progenitor cells via repression of the 
genes encoding cell cycle inhibitors, as well as inhibiting pre-
mature activation of terminal differentiation–associated genes 
(Sen et al., 2008, 2010; Ezhkova et al., 2009; LeBoeuf et al., 
2010; Fessing et al., 2011; Mardaryev et al., 2014).
Polycomb chromatin-remodeling proteins form two com-
plexes (Polycomb repressive complex 1 and 2 or PRC1/2) that 
compact the chromatin and inhibit transcription by prevent-
ing binding of the transcription machinery to gene promoters 
(Simon and Kingston, 2013; Cheutin and Cavalli, 2014). Recent 
data reveal that binding of the noncanonical PRC1 complex 
containing histone demethylase KDM2B, PCGF1, and RING/
YY1-binding protein (RYBP) promotes basal ubiquitylation of 
the H2A at lysine 119 (H2AK119) at unmethylated CpG-rich 
DNA regions, which is sufficient to recruit the PRC2 complex 
(Blackledge et al., 2014; Cooper et al., 2014; Kalb et al., 2014). 
The PRC2 component Ezh1/Ezh2 histone methyltransferase 
promotes trimethylation of H3K27, followed by targeting of 
the Cbx proteins as a part of the canonical PRC1 complex to 
H3K27me3, which result in further increase of the H2AK119 
ubiquitylation catalyzed by the PRC1 component Ring1b 
(Simon and Kingston, 2013; Cheutin and Cavalli, 2014; Perdig-
oto et al., 2014; Schwartz and Pirrotta, 2014).
In the epidermis, the Polycomb components Bmi1, 
Ezh1/2, and Jarid2 stimulate proliferation of the progenitor 
cells via repression of the genes encoding cell cycle inhibitors, 
including the INK4A–INK4B locus, as well as inhibit prema-
ture activation of terminal differentiation–associated genes (Ez-
hkova et al., 2009; Mejetta et al., 2011). In addition, Ezh1/2 
restricts differentiation of the epidermal progenitor cells by re-
pressing the Sox2 gene, which, in turn, promotes Merkel cell–
specific differentiation (Bardot et al., 2013).
The Cbx4 gene belongs to the PRC1 family and has a 
chromodomain interacting with the H3K27me3 histone mark 
and mediating transcriptional repression together with the 
PRC2 complex (Li et al., 2007; Luis et al., 2011). Cbx4 also 
possesses SUMO E3 ligase activity that promotes sumoylation 
of other proteins, including DNA methyltransferase Dnmt3a, 
thus providing a link between Polycomb-mediated gene silenc-
ing and DNA methylation (Li et al., 2007). In normal human 
skin, the Cbx4 protein protects epithelial stem cells from senes-
cence through PRC-dependent repression of the Ink4a locus, as 
well as controls their differentiation through PRC-independent 
mechanisms (Luis et al., 2011). These data suggest Cbx4 as 
a critical determinant regulating the activity of stem cells and 
their progenies in the skin. However, its role in the control of 
epidermal development and in establishing tissue-specific gene 
expression patterns still remains unclear.
Here, we show that Cbx4 is a critical determinant regu-
lating the establishment and maintenance of the epidermal dif-
ferentiation program that represses nonepidermal lineage genes 
and controls cell proliferation/differentiation in the epidermis. 
We also show that Cbx4 serves as a direct p63 target and me-
diates its repressive effects on the expression of nonepidermal 
lineage genes and selected cell cycle inhibitor genes. These data 
illustrate how p63 transcription factor operates in concert with 
epigenetic regulator Cbx4 to establish and maintain the lin-
eage-specific program in differentiating cells and in governing 
epithelial differentiation/function.
Results
Cbx4 expression is increased in the 
epidermal KCs during the stratification 
stage of epidermal development
To perform the genome-wide analysis of transcriptomes in epi-
dermal progenitor cells during development, we used laser cap-
ture microdissection (LCM) and obtained RNA samples from 
the basal epidermal layer before and after the onset of epider-
mal stratification (E11.5 and E16.5, respectively), as well as 
postnatally at 1.5 d (P1.5) and 8 wk (P56, adult) as described 
previously (Sharov et al., 2006). Detailed analysis of the tran-
script levels of different Polycomb group genes revealed their 
dynamic expression during development of the mouse epider-
mis (Fig. S1 A and Table S1). Among the PRC1 genes, the 
Cbx4 transcript and protein levels were strongly increased in the 
basal KCs during the transition from single-layered epithelium 
to stratified squamous epidermis (E11.5 vs. E16.5; Fig. 1, A and 
B; Fig. S1 A; and Table S1). Consistent with previous observa-
tions (Ezhkova et al., 2009), the onset of epidermal stratification 
(E11.5–E16.5) was also characterized by the highest levels of 
the PRC2 component Ezh2 gene expressions in the basal KCs, 
followed by its decline at the later stages of epidermal differen-
tiation (E16.5–P1.5; Fig. S1 A and Table S1).
Interestingly, Cbx4 protein expression was even higher 
in differentiating suprabasal KCs, whereas significantly lower 
expression levels were seen in the dermal compartment of the 
skin (Fig. 1, B and D). In contrast to Cbx4, other PRC1 genes 
showed a less pronounced increase, or even a decrease, in their 
expression levels at the early stages of epidermal development 
(Fig. S1 A). As the epidermis fully matured (P1.5), basal pro-
genitor cells showed a decline in expression of most of the PRC1 
genes except Cbx7, Phc1, and Pcgf1 (Fig. S1 A and Table S1). 
Interestingly, Cbx4 expression levels also decreased in the basal 
KCs of adult skin compared with E16.5, but were still consid-
erably higher than at E11.5 (Fig. 1 C, Fig. S1 A, and Table S1).
Cbx4 controls KC proliferation 
and terminal differentiation in the 
developing epidermis
To uncover the role of Cbx4 in the epidermal progenitor cells 
during development, we used mice bearing an inactivation allele 
lacking the first two exons and a 0.9-kb upstream region of the 
Cbx4 gene disrupting functional Cbx4 protein synthesis (Liu et 
al., 2013). The Cbx4 homozygous KO mice were not viable and 
died within 1 h after birth because of some (not yet fully clear) 
developmental abnormalities, including thymic hypoplasia (Liu 
et al., 2013). Immunostaining analysis for Cbx4 confirmed the 
abolished protein expression in the skin of Cbx4KO compared 
with wild-type (WT) littermates (Fig. 1 B).
To explore the skin phenotype upon Cbx4 ablation, we per-
formed a histological assessment of the stratified skin epithelium at 
different developmental time points: E14.5, E16.5, and E18.5. At 
E14.5, Cbx4-null epidermis showed significantly reduced thick-
ness correlated with a decreased number of stratified cellular lay-
ers and significant reduction in the number of proliferating Ki67+ 
cells in the basal layer compared with WT controls (Fig. 1, E–H). 
Similar to E14.5, Cbx4-null epidermis remained significantly 
thinner and harbored fewer proliferating basal cells at E16.5, 
whereas such differences become insignificant at E18.5 (Fig. 1, 
E–H). At E16.5, the appearance of the senescence-associated 
marker γ-H2AX was seen in the epidermis of Cbx4KO mice, 
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whereas immunostaining for active caspase 3 showed a lack of 
any changes in the KC apoptosis between WT and Cbx4KO mice 
(Fig. S3, E and F). The reduced proliferation of E16.5 basal epi-
dermal KCs was associated with increased expression of the cell 
cycle inhibitor genes (senescence-linked Ink4a locus p16/p19 
and Cdkn1c/p57 gene; Fig. S3, A and B), which are well-known 
targets of the Polycomb proteins in several tissues, including the 
skin (Ezhkova et al., 2009; Luis et al., 2011).
As CBX4 was previously shown to prevent terminal dif-
ferentiation in human epidermal progenitor cells independently 
of its Polycomb-associated repressive function (Luis et al., 
2011), we explored the effect of Cbx4 ablation on the expres-
sion of early and late epidermal differentiation genes in the de-
veloping mouse epidermis. In the absence of Cbx4, cells of the 
embryonic ectoderm were able to acquire an epidermal fate and 
commence a differentiation program as indicated by positive 
K14 and K10 staining in the basal and suprabasal cells (Figs. 1 I 
and S4 A). However, Loricrin, a marker of terminally differ-
entiating KCs, was prematurely expressed in the suprabasal 
cells located just above the basal cells in the Cbx4-deficient 
epidermis at E14.5, whereas its expression was not detectable 
in WT epidermis at this stage (Figs. 1 J and S4 A). In E16.5 
WT embryos, the most superficial late suprabasal cells under-
went terminal differentiation and expressed the key components 
of the cornified cell envelope such as Loricrin, Involucrin, and 
Filaggrin (Figs. 1 J and S4 A). In contrast to WT mice, the pre-
mature onsets of Loricrin, Involucrin, and Filaggrin expression 
were seen in the early suprabasal cells in E16.5 Cbx4KO mice 
(Figs. 1 J and S4 A). Immunofluorescence data on the expres-
sion of the markers of terminally differentiated KCs were in 
concordance with quantitative real time–PCR (qRT-PCR) data 
showing the markedly elevated levels of the Lor, Inv, and Flg 
Figure 1. Cbx4KO mice show a decrease of cell proliferation and premature terminal differentiation in the developing epidermis. (A) Cbx4 transcript 
expression in epidermal KCs at E11.5, E16.5, and P1.5 (qRT-PCR; mean ± SD; n = 3). (B) Cbx4 immunofluorescence is not detected in the E11.5 epider-
mis. In comparison to E11.5, Cbx4 levels are increased in basal and suprabasal KCs at E16.5, as well as in postnatal (P56) skin (arrows). Cbx4KO mice 
show a lack of Cbx4 expression in the epidermis. Integrin-β4 (Itgb4) expression outlines the basement membrane of the epidermis. DAPI counterstain (blue) 
shows the nuclei. (C) Quantification of Cbx4+ cells in the epidermis at different developmental stages in WT mice and in Cbx4KO skin (mean ± SD). n = 3.  
(D) Quantification of Cbx4 total cell fluorescence in both epidermal and dermal skin compartments of WT mice at E16.5 (box plot with 5–95% confidential 
intervals; the whiskers show minimum and maximum values). n = 3. (E and F) Histomorphological analyses of the alkaline phosphatase/hematoxylin-stained 
skin showed a reduced epidermal thickness in Cbx4KO mice compared with WT mice at E14.5 and E16.5 (mean ± SD). n = 3. Dashed lines separate 
epidermis and dermis. (G and H) Immunofluorescence detection (H) and quantification (G) of Ki67+ cells (H, arrows) showed reduced cell proliferation in 
the Cbx4KO epidermis versus WT counterpart at E14.5 and E16.5 (box plot with 5–95% confidential intervals). n = 4. Integrin-β4 expression outlines the 
basement membrane of the epidermis. (I and J) Immunofluorescence detection of K14 and K10 (I) and late (J) differentiation markers revealed premature 
onset of the terminal differentiation in the Cbx4KO epidermis (dashed lines indicate the epidermal/dermal border). In Cbx4KO mice, Loricrin protein was 
detected as early as E14.5, before onset of terminal differentiation in WT mice (J). At E16.5, Loricrin and Filaggrin were detected in early suprabasal cells, 
whereas Involucrin expression was up-regulated already in the basal progenitor cells (arrows). Brackets and asterisks depict the positions of the spinous 
and granular epidermal layers, respectively. (K) Increase of the Lor, Ivl, and Flg mRNA levels in the LCM-captured basal epidermal cells of E16.5 Cbx4KO 
mice versus WT controls (mean ± SD). n = 3. ***, P < 0.001. Bars, 25 µm. ns, not significant.
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transcripts in the E16.5 epidermis of Cbx4KO mice versus WT 
controls (Fig.  1 K). Thus, Cbx4 suppresses the expression of 
terminal differentiation–associated genes in the basal progeni-
tor cells during murine epidermal development.
Cbx4 represses nonepidermal lineage genes 
in KCs during epidermal development
Next, we analyzed the distribution of H2AK119Ub and 
H3K27me3, two key histone modifications associated with 
Polycomb-mediated gene repression, in the epidermis of 
Cbx4KO mice. According to the model of Polycomb-mediated 
gene silencing, a basal level of H2AK119 ubiquitylation at un-
methylated CpG-rich DNA regions is maintained by noncanon-
ical PRC1 complexes lacking the Cbx proteins, whereas one 
of the Cbx family members serving as a part of the canonical 
PRC1 complex is only involved in the subsequent step in the 
Polycomb-mediated gene silencing and is required for bind-
ing to H3K27me3, followed by the Ring1b-mediated further 
increase of the H2AK119 ubiquitylation over its basal level 
(Simon and Kingston, 2013; Cheutin and Cavalli, 2014; Perdig-
oto et al., 2014; Schwartz and Pirrotta, 2014).
In contrast to WT mice, epidermal cells in E14.5 and 
E16.5 Cbx4KO mice showed a significantly decreased level of 
H2AK119ub1 expression, which we considered as a basal level 
(Fig. 2, A and B). However, the expression levels of H3K27me3 
were not changed in the epidermis of Cbx4KO mice compared 
with WT controls (Fig.  2, C and D). Also, expression of the 
histone methylase Kdm2b, a constituent of the noncanonical 
PRC1 complex (Schwartz and Pirrotta, 2014), was increased in 
the epidermis of Cbx4KO mice, whereas expression of Ring1b 
forming the canonical PRC1 complex together with Cbx4 and 
catalyzing the H2AK119 ubiquitylation was not changed (Fig. 
S2, A and B). Importantly, Cbx4 ablation changed neither 
H2AK119ub1 nor H3K27me3 expression in the dermal cells 
(Fig. S2 C), thus suggesting epidermis-specific effects of Cbx4 
on gene repression in the skin. These data were consistent with 
the data showing the significantly increased Cbx4 expression 
levels in the epidermis versus dermis in WT mice (Fig. 1 D) 
and suggested that, similar to other cell lineages, Cbx4 most 
likely mediates the recruitment of the canonical PRC1 complex 
to H3K27me3, followed by further ubiquitylation of H2AK119 
over its basal levels mediated by PRC1 in epidermal cells.
Our data also demonstrate that the expression levels of 
H2AK119ub1 in the epidermis of E18.5 Cbx4KO and WT mice 
became quite similar (Fig.  2, A and B), which suggests that 
other Cbx proteins (Fig. S1 C) might substitute for Cbx4 in the 
canonical PRC1 complex in Cbx4KO mice. These data are also 
quite consistent with the data demonstrating that maximal dif-
ferences in the epidermal thickness and proliferation between 
WT and Cbx4KO mice are seen at E16.5, whereas such differ-
ences become insignificant at E18.5 (Fig. 1, E–H).
To determine the molecular targets of Cbx4 in the epi-
dermal KCs during development, we correlated a microarray 
transcript profiling from E16.5 LCM-captured Cbx4-deficient 
basal cells with Cbx4 chromatin immunoprecipitation (ChIP) 
sequencing (ChIP-seq) analyses performed on primary epi-
dermal KCs isolated from E16.5 WT mice. About 13.8% of 
genes up-regulated in the basal epidermal cells from Cbx4KO 
mice showed Cbx4 ChIP-seq binding, thus likely representing 
direct Cbx4 targets in KCs (Fig.  2, E–G). Because the Cbx4 
chromodomain binds to H3K27me3, which results in a further 
increase of the H2AK119 ubiquitylation over its basal levels 
catalyzed by the PRC1 component Ring1b (Li et al., 2007; 
Luis et al., 2011), we merged data for direct Cbx4 targets and 
ChIP-seq data for H3K27me3 and found that 60.9% of Cbx4 
direct target genes in primary epidermal KCs show peaks for 
both Cbx4 and H3K27me3 within 100 kb of their transcription 
start sites (Fig. 2 E and Table S5). Furthermore, 12.1% of these 
genes showed the overlapping ChIP-seq peaks for Cbx4 and 
H3K27me3, thus pointing to these genes as direct targets for 
Cbx4-mediated repression (Table S5).
The DAV ID bioinformatics tool for gene ontology func-
tional annotation revealed an enrichment of the genes involved 
in the control of neuronal development among the Cbx4 targets 
(Fig. 2, F and G; and Table S5). In primary epidermal KCs, sev-
eral neuronal and other lineage-specific genes (Nefl, Neurog3, 
Mobp, En2, and Lhx4) contained both Cbx4 and H3K27me3 
ChIP-seq peaks in their regulatory regions (Fig. 2 H). Validation 
by qRT-PCR showed increased transcript levels of the selected 
Cbx4 target genes in the Cbx4-null epidermal cells (Fig. 2 I), 
including the Nefl and Mobp genes encoding a neurofilament 
light polypeptide and myelin-associated oligodendrocyte basic 
protein, structural components of the neurons, and Schwann 
cells, respectively (Montague et al., 1997; Jordanova et al., 
2003). In addition, expression of the Neurog3, Olig2, En2, and 
Lhx4 genes, encoding the corresponding transcription factors 
controlling the development of nervous system and some other 
non–KC cell lineages (Hobert and Westphal, 2000; Wallén and 
Perlmann, 2003; Pelling et al., 2011; Mitew et al., 2014), was 
markedly increased in the epidermis of Cbx4KO mice com-
pared with WT controls (Fig. 2 I).
Interestingly, Nefl transcript levels showed an inverse cor-
relation with Cbx4 expression in the WT epidermis during E11.5–
E16.5 (Figs. 1 A, 2 I, and S1 C). Further analysis revealed that, 
in addition to the dermal nerve fibers, an ectopic expression of 
the Nefl protein was seen in both basal and suprabasal epidermal 
layers of E16.5 Cbx4KO mice, whereas an exclusively neuronal 
Nefl expression was seen in WT mice (Fig. 2 J). Furthermore, 
ChIP–quantitative PCR (ChIP-qPCR) analyses showed enrich-
ments for Cbx4, H2AK119ub1, and H3K27me3 at the regulatory 
region of the Nefl gene, whereas a lack of Cbx4 enrichment was 
seen at the regulatory region of the Lor gene that did not belong 
to the category of the Cbx4 direct targets and served as a control 
in this experiment (Fig. 2 K). In addition, shRNA-mediated Cbx4 
gene silencing resulted in a significant decrease in the Cbx4 and 
H2AK119ub1 levels at the regulatory region of the Nefl gene in 
primary epidermal KCs, whereas the H3K27me3 levels were not 
changed (Figs. 2 L and S2 D). These data were consistent with 
the data demonstrating the decrease in the H2AK119ub1 levels in 
the epidermis of Cbx4KO versus WT mice (Fig. 2, A and B) and 
suggest that Cbx4 as a part of the canonical PRC1 complex facil-
itates repression of its target Nefl gene. However, Cbx4 ablation 
did not affect Merkel cell numbers in the developing epidermis or 
expression of the transcription factors (Atoh1 and Sox2) involved 
in their differentiation (Fig. 4, B and C; and Table S5; Van Key-
meulen et al., 2009; Bardot et al., 2013; unpublished data).
Chromodomain- and SUMO E3 ligase–
dependent Cbx4 activities differentially 
regulate proliferation, differentiation, and 
expression of nonepidermal genes in KCs
As Cbx4 uniquely possesses, among PRC1-associated Cbx 
subunits, both Polycomb and non-Polycomb SUMO E3 li-
gase activities (Li et al., 2007; Luis et al., 2011), we next 
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questioned whether its effects on epidermal proliferation, 
differentiation, and repression of nonepidermal genes seen 
during murine skin development are associated with one of 
these Cbx4 activities. We infected primary epidermal KCs 
isolated from newborn WT mice with retroviral constructs 
expressing either WT Cbx4 (Cbx4WT), chromodomain- 
mutated Cbx4 (Cbx4CDM), or E3 ligase–deficient Cbx4 
(Cbx4ΔSIM; Luis et al., 2011).
Interestingly, transfection of cells with Cbx4WT or Cbx4CDM 
constructs did not show any effect on the number of proliferating 
Ki67+ cells, whereas a prominent decrease in proliferation was seen 
in the cells expressing the E3 ligase–deficient Cbx4ΔSIM construct 
(Fig. 3, A and B). These data were consistent with the data show-
ing the decrease of epidermal proliferation in Cbx4KO mice (Fig. 1, 
G and H) and suggest that the effects of Cbx4 on proliferation in 
cultured KCs are mediated predominantly by its E3 ligase domain.
Figure 2. Activation of nonepidermal lineage genes in Cbx4-deficient epidermis. (A and B) Distribution and quantification of H2AK119ub1 immunofluo-
rescence in WT and Cbx4KO skin. H2AK119ub1 is markedly reduced in the Cbx4KO epidermis at E14.5 and E16.5, whereas its expression is restored 
by E18.5. (C and D) Lack of changes in the cutaneous H3K27me3 expression between WT and Cbx4KO mice. Dashed lines separate epidermis and 
dermis. (E) Overlap of the Cbx4 and H3K27me3 ChIP-seq data with the expression arrays obtained from the epidermis of Cbx4KO versus WT mice depicts 
the direct Polycomb-dependent Cbx4 target genes in KCs that are up-regulated upon Cbx4 ablation. (F) Ontology of the Cbx4 target genes using DAV ID 
bioinformatic resources. The bars represent the log10 p-values of each category. (G) Selected Cbx4 target genes involved in neuronal development and/
or functioning. (H) ChIP-seq tracks depicting Cbx4 and H3K27me3 binding to the selected target genes (a single representative experiment out of two 
repeats is shown). Dashed outlines depict the corresponding gene regulatory regions. (I) qRT-PCR validation of the selected Cbx4 target genes up-regulated 
in the basal progenitor cells from Cbx4KO mice versus WT controls (mean ± SD). n = 3. (J) Ectopic Nefl protein expression in the Cbx4KO epidermis (ar-
rowheads) compared with WT counterparts. Asterisks denote Nefl+ dermal nerve fibers in the WT and Cbx4KO mice. (K) ChIP-qPCR shows Cbx4 binding 
to Nefl but not to Lor promoter regions. Both Lor and Nefl are enriched in H2AK119ub1 and H3K27me3 histone marks (mean ± SD). n = 3. (L) Cbx4 
knockdown in primary mouse KCs with shRNA decreases Cbx4 binding and reduces the H2AK119ub1 enrichment on the Nefl promoter region (mean ± 
SD). n = 3. **, P < 0.01; ***, P < 0.001. Bars, 25 µm. ns, not significant.
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Given that Cbx4 suppresses senescence in human epi-
dermal KCs (Luis et al., 2011), we examined the mechanisms 
underlying the Cbx4-dependent regulation of the senescence- 
linked cell cycle inhibitor genes and performed ChIP-qPCR 
analyses that revealed Cbx4 binding to the Cdkn2a (p16/
p19) regulatory regions in primary epidermal KCs (Fig. S3 
C). Transfection of primary epidermal KCs with Cbx4WT or 
Cbx4CDM constructs showed that the Cbx4 chromodomain is 
involved in regulating the expression of Cdkn2a and Cdkn1c 
(p57; Fig. S3 D). Together with our data demonstrating an in-
crease in the expressions of p16/p19, p57, and the senescence 
marker γ-H2AX in the epidermis of Cbx4KO mice versus 
WT controls (Fig. S3, A, B, and E), these data demonstrated 
an involvement of the Cbx4 chromodomain in the control 
of expression of the senescence-associated p16/p19 and p57 
genes. These data were in full concordance with the data of 
Luis et al. (2011) that show similar effects of the Cbx4 chro-
modomain on the expression of senescence-associated genes 
in human epidermal KCs.
To assess whether targeting of Cbx4 in the primary 
KCs affects cell differentiation, we analyzed the expression 
of two established terminal differentiation–associated markers 
(Involucrin and Filaggrin) after infection of cells with the WT 
or mutated Cbx4-expressing retroviruses. Cbx4WT-expressing 
cells showed a decrease in protein and gene expression of In-
volucrin in comparison with control cells (Fig.  3, C and D). 
However, Cbx4ΔSIM-treated KCs showed a prominent in-
crease of Involucrin protein and gene expression compared 
with Cbx4WT- or Cbx4CDM-treated cells (Fig. 3, C, D, and 
G). Furthermore, transcripts of Flg were also increased upon 
Cbx4ΔSIM overexpression compared with the Cbx4WT and 
Cbx4CDM constructs (Fig.  3  H). Thus, similar to human 
epidermal progenitor cells (Luis et al., 2011), expression of 
terminal differentiation markers in mouse KCs occurs pre-
dominantly under the control of non-Polycomb SUMO E3 
ligase activity of Cbx4.
To further elucidate which of the Cbx4 activities were 
likely responsible for repression of the nonepidermal lineage 
genes, we analyzed Nefl expression in the response to over-
expression of the Cbx4 constructs harboring either chromo-
domain- or SUMO E3 ligase–mutated domains. A marked 
increase of both Nefl transcript and protein expression was 
detected in the Cbx4CDM-expressing cells compared with 
Cbx4WT and Cbx4ΔSIM (Fig. 3, E, F, and I). Thus, Cbx4 re-
presses neuronal gene Nefl in epidermal KCs predominantly via 
the Polycomb-mediated inhibitory pathway.
Figure 3. SUMO E3 ligase– and chromodomain-dependent activities of Cbx4 in the epidermal progenitor cells. (A–F) Immunofluorescent detection and 
quantification of Ki67 (A and B), Ivl (C and D), and Nefl (E and F) expression in the primary mouse KCs infected with Cbx4WT-, Cbx4CDM-, and Cbx-
4ΔSIM-expressing retroviruses. The number of Ki67+-proliferating cells is significantly reduced, whereas Ivl expression is markedly increased in Cbx4Δ-
SIM-expressing KCs. In contrast, Nefl expression is up-regulated in Cbx4CDM-expressing cells (mean ± SD). n = 3. Bars, 50 µm. (G and H) qRT-PCR shows 
increased Ivl (G) and Flg (H) transcription in Cbx4ΔSIM-expressing cells (mean ± SEM). n = 3. (I) Increased levels of the Nefl transcripts in primary mouse 
KCs infected with Cbx4CDM-expressing retrovirus (mean ± SEM). n = 3. *, P < 0.05; **, P < 0.01; ***, P < 0.001. ns, not significant.
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Cbx4 is a direct p63 target mediating 
its inhibitory activity on nonepidermal 
genes in KCs
p63 is a major transcriptional regulator of epidermal develop-
ment with multiple functions, including a direct positive tran-
scriptional regulation of epidermal genes such as keratins and 
adhesion molecules (Koster and Roop, 2007; Vanbokhoven et 
al., 2011; Botchkarev and Flores, 2014; Kouwenhoven et al., 
2015). A recent study has also highlighted an important role for 
p63 in suppression of nonepidermal lineage genes (De Rosa et 
al., 2009). To test whether p63-dependent suppression of the 
nonepidermal genes is mediated by Cbx4, we compared the 
transcriptomes of epidermal cells isolated by LCM from E18.5 
Cbx4KO and p63KO embryos. A significant portion (34.7%) of 
the genes (716 out of 2,059) up-regulated in the p63-deficient 
KCs were also up-regulated in Cbx4KO basal epidermal cells, 
suggesting a functional link between p63 and Cbx4 (Fig. 4 A 
and Table S2). Furthermore, ChIP-seq analyses showed that 
72 of these genes, including the Nefl gene, served as direct 
Cbx4 targets in KCs (Fig. 4 A and Table S2). The expression 
changes of the Nefl gene were further validated by qRT-PCR 
in p63-deficient KCs isolated from p63KO embryos and p63 
siRNA–treated primary mouse KCs (Fig. 4, B and C). Similar 
to Cbx4KO epidermal cells, p63-deficient skin epithelial cells 
showed strongly up-regulated Nefl protein expression com-
pared with WT cells (Fig. 4, D and E), further substantiating 
functional cooperation between p63 and Cbx4 in the repression 
of nonepidermal genes in the developing epidermal KCs.
To further investigate the relationships between p63 and 
Cbx4, we analyzed Cbx4 expression in p63KO embryonic skin. 
Both the Cbx4 transcript and protein levels were markedly re-
duced in the p63-deficient KCs (Fig.  4, F–H). Interestingly, 
in p63KO dermal cells, Cbx4 protein expression was detect-
able at similar levels to control mice (Fig. 4 G), suggesting a 
KC-specific Cbx4 regulation by p63 transcription factor. By 
using a PatSearch tool (Grillo et al., 2003), we identified a 
highly conserved region ∼5.5 kb upstream of the Cbx4 tran-
scription start site containing several putative p63-binding sites 
(Fig. 4 I). Furthermore, ChIP revealed binding of the p63 tran-
scription factor to the identified region in primary mouse KCs 
in vivo (Fig. 4 J). We cloned a 2.4-kb Cbx4 5′ UTR fragment, 
containing the putative p63-binding sites as an enhancer, into 
the pGl3 promoter plasmid (pGl3-Cbx4-luc) and coexpressed 
it with either ΔNp63-expressing or empty vector in the im-
mortal KC HaCaT cell line. A marked increase in luciferase 
activity was seen in cells coexpressing pGl3-Cbx4-luc with 
pΔNp63 vectors compared with a control plasmid (pFLAG-
CMV2; Fig. 4 K), thus showing a direct transcriptional regula-
tion of Cbx4 by p63 in KCs.
Ectopic Cbx4 expression partially rescues 
the epidermal phenotype in embryonic skin 
explants of p63-deficient mice
To assess whether the restoration of Cbx4 expression is capable 
of partially rescuing the skin phenotype of p63KO mice, E13.5 
skin explants isolated from p63 heterozygous (p63+/−) mice 
were cultured ex vivo and infected with p63 shRNA–expressing 
lentiviruses in combination with either Cbx4-expressing or con-
trol lentiviruses (Fig. 5, A–E). Compared with the p63+/− skin 
explants treated with control viruses, treatment with p63 shRNA 
in combination with control lentiviruses resulted in a marked 
decrease of the epidermal thickness, cell proliferation, and ex-
pressions of epidermal keratins K14 and K10, thus reproducing 
in part the skin phenotype of p63KO mice (Fig. 5, A–E). How-
ever, cotreatment of p63+/− skin samples with p63 shRNA– and 
Cbx4-expressing lentiviruses resulted in a significant increase of 
epidermal thickness, cell proliferation, and K14/K10 expression 
compared with the samples treated with p63 shRNA and control 
lentiviruses (Fig.  5, A–E). The restoration of epidermal prolif-
eration after ectopic Cbx4 expression was consistent with data 
showing reduced cell proliferation in the epidermis of Cbx4KO 
mice compared with WT controls (Fig. 1, G and H). Furthermore, 
the Nefl protein was strongly decreased in the epithelium of p63- 
deficient embryonic skin explants transduced with Cbx4 (Fig. 5, 
D and E), suggesting that Cbx4 is indeed capable of inhibiting its 
expression in epidermal KCs ex vivo. Therefore, Cbx4 plays a 
role in mediating the p63-dependent program of gene repression 
during epidermal development and is capable of partially restor-
ing the epidermal phenotype of p63-deficient mice.
Discussion
Polycomb-dependent transcriptional repression is a powerful 
mechanism that shapes gene expression programmers in es-
sentially all cell types of living organisms during development 
and postnatal homeostasis, whereas alterations in the patterns 
of Polycomb-dependent gene repression contribute to many 
pathological conditions including carcinogenesis (Simon and 
Kingston, 2013). Polycomb PRC1 and PRC2 are multiprotein 
complexes, and despite the fact that the role of some Polycomb 
genes, such as Ezh1/2, in execution of terminal differentiation 
programmers in the epidermis and hair follicles was shown pre-
viously (Ezhkova et al., 2009, 2011), the effects of the other 
PRC1/2 components on the establishment of lineage-specific 
patterns of gene repression during skin development and epi-
dermal differentiation remain unclear. Here, we show that 
PRC1 component Cbx4 plays a unique role in the establishment 
and maintenance of the KC lineage identity and represses none-
pidermal lineage (neuronal) genes in the epidermal progenitor 
cells, as well as controls proliferation and inhibits premature 
differentiation in basal epidermal KCs.
We demonstrate that among different PRC1 genes, Cbx4 
shows the most prominent changes in its expression in the em-
bryonic epidermis during its stratification, where Cbx4 is seen 
in basal and suprabasal KCs. Genetic Cbx4 ablation results in 
a marked decrease of epidermal thickness and proliferation, as 
well as in the premature appearance of the terminal differen-
tiation markers in the immediate suprabasal epidermal cells. 
Interestingly, Ezh2KO mice also show a decrease of epidermal 
proliferation and premature terminal differentiation (Ezhkova 
et al., 2009). Similar to Ezh2KO mice (Ezhkova et al., 2009), 
Cbx4-null mice show an increase of the p16/p19 and p57 cell 
cycle inhibitor genes in the epidermis, which, at least in part, 
explains the stimulatory effects of Cbx4 on epidermal prolifer-
ation. However, in contrast to Ezh2KO mice, Cbx4 genetic ab-
lation results in a marked decrease of the epidermal thickness, 
suggesting that Cbx4 plays a unique yet partially overlapping 
role with Ezh2 in the control of epidermal development.
The decreased cell proliferation observed in the epider-
mis upon Cbx4 ablation is consistent with our previous results 
that show reduced cell proliferation and thymus hypoplasia in 
Cbx4KO mice (Liu et al., 2013). In contrast to other Cbx proteins, 
Cbx4 uniquely possesses both Polycomb and non-Polycomb 
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SUMO E3 ligase activities (Li et al., 2007; Luis et al., 2011). 
We show here that in cultured primary epidermal KCs, only the 
non-Polycomb E3 ligase–deficient Cbx4 (Cbx4ΔSIM) is capa-
ble of inhibiting proliferation, suggesting that the SUMO E3 li-
gase activity of Cbx4 contributes to the alterations of epidermal 
proliferation in Cbx4KO mice.
Interestingly, KCs treated with Cbx4ΔSIM also show a 
marked increase in the expression of terminal differentiation– 
associated markers, such as Involucrin or Filaggrin, thus suggest-
ing that non-Polycomb SUMO E3 ligase Cbx4 activity might also 
inhibit the premature activation of terminal differentiation genes 
in the epidermis. These data are consistent with data demonstrat-
ing an involvement of SUMO E3 ligase Cbx4 activity in inhib-
iting differentiation in human epidermal progenitor cells (Luis 
et al., 2011). However, additional analyses are required to fully 
understand the mechanisms underlying the effects of the SUMO 
E3 ligase domain of Cbx4 in regulating gene expression in KCs.
Our data also reveal that the Cbx4 chromodomain is in-
volved in the repression of the senescence-associated Cdkn2a 
gene, whereas Cbx4 ablation results in the accumulation of 
H2AX as one of the senescence markers (Turinetto and Gia-
chino, 2015) in epidermal KCs. These data are in full con-
cordance with the data of Luis et al. (2011) that show similar 
effects of the Cbx4 chromodomain on the expression of senes-
cence-associated genes in human epidermal KCs.
Histone methyltransferase Ezh2 catalyzing H3K27 
trimethylation plays an important role in the prevention of 
premature activation of terminal differentiation genes in basal 
epidermal KCs (Ezhkova et al., 2009). The Cbx4 chromo-
domain mediates the targeting of the canonical PRC1 complex 
to H3K27me3, leading to the increase of H2AK119 ubiquityl-
ation over its basal levels catalyzed by the PRC1 component 
Ring1b (Simon and Kingston, 2013; Cheutin and Cavalli, 2014; 
Perdigoto et al., 2014; Schwartz and Pirrotta, 2014). Although 
Figure 4. Cbx4 serves as a direct p63 target in epidermal KCs. (A) Overlap of the Cbx4 target genes commonly up-regulated in laser-captured epidermis 
of E16.5 Cbx4KO and p63KO mice. (B and C) qRT-PCR validation of Nefl gene up-regulation in the epidermal progenitor cells in p63KO mice (B) and 
primary epidermal KCs expressing p63 shRNA (C; mean ± SD). n = 3. (D) Increased Nefl protein expression in the epidermis of p63 mutant mice (arrow-
heads). Nefl-expressing dermal nerve fibers are shown by arrows. Dashed lines separate epidermis and dermis. (E) The number of Nefl+ epidermal cells 
is significantly increased in p63KO mice (mean ± SD). n = 3. (F and G) Cbx4 transcript (F) and protein (G) are markedly down-regulated in the epidermis 
of p63KO mice (mean ± SD). n = 3. Dashed lines separate epidermis and dermis. (H) A significant reduction in the number of Cbx4+ cells in p63KO skin 
compared with WT skin (mean ± SD). n = 3. (I) Conserved putative p63-binding sites are identified by the PatSearch tool in the mouse and human Cbx4 5′ 
UTR. Asterisks indicate consensus sequences for p63-binding sites, and core sequence elements are indicated by red asterisks. (J) ChIP-qPCR showing p63 
binding to the identified region in the mouse Cbx4 5′ UTR. (K) A 2.4-kb region in the Cbx4 5′ UTR increases minimal SV40-promoter activity (pGl3-Cbx4-
luc) upon coexpression with a ΔNp63-expressing construct compared with an empty plasmid (pFLAG-CMV2). Bars, 25 µm. **, P < 0.01; ***, P < 0.001.
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the levels of H3K27me3 were not altered in the epidermis of 
Cbx4KO mice, Cbx4 ablation resulted in a marked decrease 
in H2AK119Ub in the epidermis (presumably to its basal lev-
els) compared with WT controls. The fact that Cbx4-null mice 
showed reduced levels of H2AK119Ub only in the epidermis, 
whereas H2AK119Ub levels in the dermal cell were not altered 
upon Cbx4 ablation compared with WT controls, points to the 
specificity of this interaction.
Interestingly, Cbx4 ablation is also accompanied by an in-
crease of epidermal expression of Kdm2b histone demethylase 
that forms a noncanonical PRC1 complex together with PCGF1 
and RYBP and promotes basal ubiquitylation of H2AK119 at 
unmethylated CpG-rich DNA regions (Blackledge et al., 2014; 
Cooper et al., 2014; Kalb et al., 2014). These data suggest that 
interaction of the noncanonical PRC1 complex with gene tar-
gets is likely not altered in the epidermis of Cbx4KO mice and 
that the Cbx4 chromodomain is specifically involved in the 
execution of the canonical PRC1-mediated gene repression 
in the epidermis via interaction with H3K27me3 followed by 
H2AK119 ubiquitylation.
However, a correlation between the Cbx4 and Ezh1/2 
ChIP-seq targets in epidermal KCs might help in addressing the 
roles for PRC1 and PRC2 complexes in repressing the activities 
of the distinct gene groups in KCs. Our data reveal a contribution 
of the Cbx4 chromodomain to the repression of non-KC lineage 
(neuronal) genes in the epidermis, which is quite consistent with 
the data obtained from the Ezh2KO mice (Ezhkova et al., 2009). 
By merging the microarray data obtained from the epidermis of 
Cbx4KO mice with Cbx4 ChIP-seq and H3K27me3 ChIP-seq 
data, we demonstrate an enrichment of the genes associated with 
nervous system development among the direct Cbx4 targets in 
KCs. We show that several key genes encoding structural com-
ponents of the neurons and Schwann cells (Nefl and Mobp) and 
transcription factors involved in the control of nervous system 
development (Neurog3, Olig2, En2, and Lhx4) are up-regulated 
in the epidermis of Cbx4KO mice compared with WT controls.
Epidermal and neuronal lineages share the common ecto-
dermal origin (Patthey and Gunhaga, 2011; Benitah and Frye, 
2012), and mechanisms that control gene repression during 
specification of these two lineages in the embryo are unclear. 
Ezh2 is strongly expressed in neural stem cells and is down- 
regulated during their differentiation into neurons and astrocytes, 
whereas its expression is increased during neural stem cell dif-
ferentiation into the oligodendrocyte lineage (Sher et al., 2008). 
Analyses of the Ezh2 targets in neural stem cells (Sher et al., 
2012) reveal that several genes encoding transcription factors in-
volved in the control of nervous system development (En2, Lhx4, 
Olig2, Pax3, and Pitx2) also represent the direct Cbx4 targets in 
epidermal KCs. These data support an idea that Cbx4, through its 
chromodomain, and Ezh2 operate in concert to repress neuronal 
genes and maintain the epithelial fate in the epidermal progenitor 
cells, whereas Ezh2 also represses their differentiation into the 
Merkel cell lineage independently of Cbx4 (Bardot et al., 2013).
Specification and differentiation of the epidermal progeni-
tor cells during development is supported by the p63 transcription 
Figure 5. Cbx4 partially rescues an epidermal phenotype in p63KO mice. 
(A and B) Hematoxylin/AP staining (A) and immunodetection of Ki67+-pro-
liferating cells (B) in E13.5 ex vivo embryonic skin explants of heterozy-
gous p63+/−KO mice treated with p63 shRNA– and Cbx4-expressing 
lentiviruses. Dashed lines separate epidermis and dermis. (C) Cbx4 over-
expression in p63-deficient epidermal cells significantly increases epi-
dermal thickness and cell proliferation (mean ± SD). n = 3.  (D and E) 
Quantitative immunofluorescence stainings with anti-K14, anti-K10, and 
anti-Nefl antibodies show down-regulation of K14/K10 and up-regulation 
of Nefl (arrows) in the epithelium of p63-deficient skin explants. Cotreat-
ment of the explants with p63 shRNA– and Cbx4-expressing lentiviruses 
results in up-regulation of K14/K10 expression and down-regulation of 
Nefl expression in p63-deficient epidermis. Integrin-β4 (Itgb4) expression 
outlines the basement membrane of the epidermis. DAPI counterstain (blue) 
shows the nuclei (mean ± SD). n = 3. **, P < 0.01; ***, P < 0.001. (F) 
Scheme summarizing the p63-/Cbx4-mediated effects on gene repression 
in the developing epidermis. Bars, 25 µm.
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factor that serves as a master regulator of epidermal development 
(Koster and Roop, 2007; Vanbokhoven et al., 2011; Botchkarev 
and Flores, 2014; Kouwenhoven et al., 2015). Increased evidence 
demonstrates that p63 regulates several components of the epi-
genetic machinery (Brg1, Lsh, and Satb1) to regulate chromatin 
remodeling and establish the epidermal differentiation program 
(Fessing et al., 2011; Keyes et al., 2011; Mardaryev et al., 2014).
We show here that p63 also operates as a direct upstream 
regulator of Cbx4, which mediates its effects on cell prolifera-
tion and is involved in the repression of non-KC lineage genes. 
We showed previously that p63 directly interacts with Cbx4 in 
thymocytes, suggesting a possibility for both proteins to form 
a transcription complex to regulate expression of target genes 
(Liu et al., 2013). Consistently, comparison of the microarray 
data from the skin epithelium of p63KO mice and epidermis 
of Cbx4KO mice reveals that ∼35% of the genes up-regulated 
in the skin epithelium of p63KO mice are also up-regulated in 
the epidermis of Cbx4 mutants, whereas ∼10% of these genes 
represent direct Cbx4 targets in KCs. Furthermore, we show 
that Cbx4 expression is markedly decreased in the skin epithe-
lium of p63KO mice, p63 shows binding to the Cbx4 regulatory 
region and stimulates Cbx4 promoter activity, and Cbx4 is ca-
pable of partially rescuing alterations of KC proliferation upon 
p63 ablation in skin organ cultures.
Collectively, these data provide compelling evidence that 
Cbx4 operates as an important part of the p63-regulated program 
of establishing and maintaining epithelial cell fate in epider-
mal progenitors and that Cbx4-mediated repression of non-KC 
lineage genes serves as a crucial component of this program 
(Fig. 5 F). However, additional analyses are required to fully un-
derstand the complexity of Cbx4-dependent gene repression in 
epidermal KCs. In particular, the role of Cbx4 in the repression 
of other lineage-specific genes, including mesodermal genes in 
KCs, and the potential contribution of these genes in the con-
trol of epithelial–mesenchymal transition need to be carefully 
explored. Also, the roles of other members of the Cbx family, 
including Cbx6 and Cbx7, which might substitute for Cbx4 in 
the canonical PRC1 complex and partially compensate for the 
effects of Cbx4 ablation in epidermal KCs, need to be clarified.
Because skin contains a large variety of the progenitor 
cells for distinct cell lineages (epithelial, neuronal, and mes-
enchymal; Hunt et al., 2009), future research in this direction 
will shed light on the role of distinct Cbx family members in 
the control of progenitor cell differentiation and/or reprogram-
ming isolated from the skin. This will also help to design novel 
approaches for modulating gene expression programmers in 
healthy and diseased skin via targeting the activity of Cbx genes.
Materials and methods
Animals and tissue collection
All animal studies were performed under protocols approved by a Home 
Office Project License. C57BL/6 mice were purchased from Charles 
River. Skin samples were collected from mice at distinct days of em-
bryonic and postnatal development (E11.5, E14.5, E16.5, E18.5, P1.5, 
and P56). p63KO embryos were obtained by breeding p63+/− animals 
purchased from The Jackson Laboratory. Generation of Cbx4KO mice 
was described previously (Liu et al., 2013). In brief, the N-terminal 
region of the Cbx4 gene including the first two exons and a 0.9-kb up-
stream region was targeted for Cbx4 gene disruption. The null allele was 
gained upon Cre-loxP excision by crossing mice carrying the floxed allele 
with EIIa-Cre transgenic mice to achieve global gene KO, and the mice 
were bred on the C57BL/6J-129Sv genetic background. Genotyping of 
mice was performed using PCR, as described previously (Liu et al., 2013). 
For each developmental stage, six to seven samples were collected. Tissue 
samples were snap frozen in liquid nitrogen, embedded into optimal cut-
ting temperature medium (VWR), and processed for immunofluorescent 
or LCM and microarray analyses as described in the following paragraph.
LCM, microarray, and qRT-PCR analysis
LCM of mouse basal KCs at selected stages of development was per-
formed followed by RNA isolation, amplification, and microarray analysis 
as previously described (Sharov et al., 2006, 2009). In brief, 8-µm-thick 
frozen skin cryosections were dehydrated to preserve RNA integrity, and 
LCM was performed from the epidermis of WT, Cbx4KO, and p63KO 
mice at E11.5, E16.5, P0.5, and P56 using an LCM system (Arcturus; Life 
Technologies). Total RNAs were isolated using an RNA isolation kit (Pi-
coPure; Life Technologies) followed by two rounds of linear RNA ampli-
fication using an RNA amplification kit (RiboAmp; Life Technologies). 
Equal amounts of RNA from each sample were labeled by Cy3 using a 
fluorescent labeling kit (Agilent Technologies). Quality and size distribu-
tion of the targets was determined by an RNA 6000 Nano Lab-on-a-chip 
assay (Agilent Technologies), and quantification was determined using 
a microscale spectrophotometer (NanoDrop). After one round of linear 
amplification in all analyses, Universal Mouse Reference RNA (Agilent 
Technologies) was used as a control. All microarray analyses were per-
formed by MOgene, LC, using the 41K Whole Mouse Genome 60-mer 
Oligo Microarray kit (Agilent Technologies). All microarray data were 
normalized to the corresponding data obtained from the reference RNA. 
Two independent datasets were obtained from WT and transgenic mice, 
and p-values were calculated by Feature Extraction software (version 7.5; 
Agilent Technologies) using distribution of the background intensity val-
ues to signal intensity and using a Student’s t test.
For qRT-PCR analysis of RNA isolated and amplified after 
LCM, PCR primers were designed on Beacon Designer software (PRE 
MIER Biosoft International; Table S3). RT-PCR was performed using 
iQ SYBR green Supermix and the MyiQ Single-Color Real-Time PCR 
Detection System (Bio-Rad Laboratories). Differences between sam-
ples and controls were calculated using the Gene Expression Macro 
program (Bio-Rad Laboratories) based on the ΔΔCt equitation method 
with glyceraldehyde 3-phosphate dehydrogenase and peptidylprolyl 
isomerase A genes as internal housekeeping controls.
Plasmids
Cbx4WT and Cbx4-mutated retroviral plasmids (Cbx4CDM and 
Cbx4ΔSIM) were previously validated (Luis et al., 2011). In brief, 
Cbx4 cDNA was cloned into pMSCV and pMSCV-Puro-IRES-
GFP. The chromodomain was mutated using the QuikChange II 
XL Site-Directed Mutagenesis kit (Agilent Technologies) to cre-
ate the F11A and W35L double mutants. In Cbx4ΔSIM plasmid (a 
gift from D.  Wotton, University of Virginia, Charlottesville, VA), 
Cbx4 cDNA was mutated to harbor internal deletion of nucleotides 
at the 784–795 and 1,381–1,404 positions, corresponding to both 
SIM1 (IVIV) and SIM2 (EVI LLDSD) amino acid sequences, re-
spectively (Merrill et al., 2010). Cbx4 knockdown was done using 
a validated shRNA construct (5′-CCG GCGAC ACCAG TAACC 
TTGGT ATCTC GAGAT ACCAA GGTTA CTGGT GTCGT TTTTG-3′)  
cloned into pLKO.1-GFP lentiviral plasmid (Morey et al., 2012). 
pGIPZ–p63 shRNA lentiviral plasmid (V3LMM_508694; GE Health-
care) contains a 5′-TGA TCTTC AGCAA CATCTC-3′ sequence and was 
used to target p63. pHAGE2-EF1-mCbx4 lentiviral plasmid was pro-
duced by cloning PCR-amplified mouse Cbx4 cDNA into pHAGE2-EF1 
vector (a gift from G. Mostoslavsky, Boston University, Boston, MA).
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Production of the Cbx4 and p63 expression and knockdown viruses
Cbx4WT-, Cbx4CDM-, and Cbx4ΔSIM-expressing retroviruses were 
produced by transfection of Phoenix-E/HEK293T packaging cells. 
Cbx4 shRNA– and p63 shRNA–expressing lentiviruses were pro-
duced by cotransfection of HEK293T cells with pLKO.1-EGFP-Cbx4 
shRNA or pGIPZ–p63 shRNA and packaging (psPAX2) and envelope 
(pMD2.G) plasmids. For Cbx4-expressing lentiviruses, HEK293T 
cells were cotransfected with pHAGE2-EF1-mCbx4 and helper plas-
mids (pTAT, pREV, pHagp2(GAG/Pol), and pVSV-G) as published 
elsewhere (Mostoslavsky et al., 2005). For Cbx4-mutated retroviruses, 
Phoenix-E cells were transfected with pMSCV-PIG-CBX4-WT, pM-
SCV-PIG-CBX4-CDM, and pMSCV-PIG-CBX4-ΔSIM plasmids as 
published previously (Luis et al., 2011). Cell culture medium con-
taining viruses was collected 24 h, 48 h, and 78 h after transfection, 
followed by precipitation of the viral particles using PEG-it solution 
(System Biosciences) as per the manufacturer’s protocol.
Primary mouse KC culture
Epidermis from newborn C57BL/6 was separated from dermis by over-
night digestion with 0.25% trypsin at 4°C. Epidermal sheath was added 
to prechilled, supplemented, low-calcium KC culture medium (MEM, 
4% FBS, 0.05-mM CaCl2, 0.4 µg/ml hydrocortisone, 5 µg/ml insulin, 10 
mg/ml EGF, 10−10-M cholera toxin, 2 × 10−9 T3, 2-mM l-glutamine, 100 
U/ml penicillin, and 100 µg/ml streptomycin). To make a single-cell sus-
pension, the epidermal tissue was chopped with scissors and triturated, 
followed by filtering through a 70-µM silicon strainer and plating onto 
collagen-coated plates and coverslips. Primary cells were grown in the 
KC culture medium at 33°C and 5% CO2 until 60–70% confluent and in-
fected with the retroviral/lentiviral particles. Cells were collected for sub-
sequent qRT-PCR or immunofluorescent analyses 48 h after infection.
FACS
A single-cell suspension of newborn epidermal KCs was prepared as de-
scribed in the previous paragraph. To ensure analysis and sorting of viable 
cells with intact chromatin, KCs were stained with UV Live/Dead Fix-
able Dye (Life Technologies) for 30 min on ice before fixation with 1% 
PFA for 10 min at RT. Fixed cells were labeled with CD49f-phycoeryth-
rin and Sca-1–FITC antibodies (Table S4) for 1 h on ice. CD49f+/Sca-1+ 
basal KCs were gated after exclusion of dead cells and sorted on a cell 
sorter (MoFlo XDP; Beckman Coulter) as described elsewhere (Jensen 
et al., 2010). Sorted cells were pelleted at 2,000 g and stored at −80°C.
Luciferase reporter assay
To make the pGl3-Cbx4-luc plasmid, a 2.4-kb Cbx4 enhancer region 
(−5,954/−3,523 bp upstream of the Cbx4 transcription start site) was 
PCR amplified from genomic DNA and cloned into the Luciferase re-
porter plasmid pGl3 promoter (Promega) at BamHI–SalI sites using 
the In-Fusion HD Cloning System (Takara Bio Inc.). For the reporter 
assay, HaCaT cells were seeded into white-bottomed/white-walled 
96-well plates at 10,000 cells/well, and transfections were performed 
after overnight incubation at 37°C. Cells were transfected with 200 ng 
DNA total plus 10 ng pRLTK Renilla Control vector (Promega): 100 ng 
pGl3-Cbx4-luc and 100 ng pΔNp63 or empty pFLAG-CMV2 vectors. 
After 48  h of incubation at 37°C, cells were washed with PBS, and 
the assay was performed using the Dual-Glo Luciferase Assay System 
(Promega) according to the manufacturer’s protocol. Firefly luciferase 
activity was normalized against the Renilla luciferase activity, and the 
data represent three independent triplicates.
Histology and immunohistochemistry
For histology and histomorphometry, 8-µm cryosections were fixed in 
4% PFA for 10 min at RT followed by hematoxylin staining and AP 
activity visualization using histoenzymatic reaction (Botchkareva et 
al., 1999, 2000; Ahmed et al., 2011, 2014). Epidermal thickness was 
measured in 10 microscopic fields using ImageJ software (National In-
stitutes of Health). For immunohistochemistry, 8-µm cryosections were 
fixed in 4% PFA for 10 min at RT and incubated with primary antibod-
ies (Table S4) overnight at 4°C, followed by application of correspond-
ing Alexa Fluor 488 and Cy-555–coupled secondary antibodies (1:200; 
Life Technologies) for 60 min at 37°C. Cell nuclei were visualized with 
4′6′-diamidino-2-phenylindol. Images were acquired on a microscope 
(Eclipse 50i; Nikon) with 20×/0.50 NA and 40×/0.75 NA Plan Fluor 
objectives (Nikon) using a digital camera (ExiAqua; QImaging) and 
Image-Pro Express 6.3 image analysis software (QImaging).
Comparative analysis of Ki67+, Ivl+, Nefl+, and Cbx4+ cells was 
done by evaluating the ratio of the number of positive cells to DAPI+ 
cells, as descried previously (Sharov et al., 2003, 2005; Mardaryev et 
al., 2011). For quantification of Ki67+ and Cbx4+ cells in tissue cryo-
sections, 10 microscopic fields (20×) from three WT and Cbx4KO skin 
sections were included in the analysis. For quantification of Ki67+, Ivl+, 
and Nefl+ cells cultured in vitro, five microscopic fields (20×) taken 
from the center and each of the four sides of the well were used in 
the analysis. Data were pooled, the means ± SD were calculated, and 
statistical analysis was performed using a two-tailed t test (α = 0.05).
Immunofluorescence intensity was determined using ImageJ soft-
ware as described previously (McCloy et al., 2014). In brief, red or green 
fluorescent signals were collected from experimental tissues in RGB for-
mat using the same exposure conditions. To measure the fluorescence 
intensity at each pixel, the RGB images were converted to 8-bit gray-
scale format. Regions of interest of distinct size were selected within WT 
or Cbx4KO epidermis and dermis, and the corrected values of total cell 
fluorescence were calculated for each selected area using the following 
formula: corrected total cell fluorescence = integrated density − (area of 
selected cell × mean fluorescence of background readings). For pairwise 
comparisons, a two-tailed t test (α = 0.05) was used. Where multiple sam-
ples were compared, a one-way analysis of variance (ANO VA) was used, 
followed by the Newman–Keuls test (α = 0.05).
ChIP-seq and ChIP-qPCR assays
ChIP was performed using epidermal KCs isolated from newborn 
mouse skin and anti-H3K27me3, anti-Cbx4, and anti-H2AK119ub1 
antibodies (Table S5). In brief, a single-cell suspension of mouse epi-
dermal KCs was prepared after overnight digestion in 5 mg/ml dispase 
(Roche) at 4°C, followed by a 5-min treatment with 0.2% trypsin (Life 
Technologies). Basal epidermal KCs were sorted by FACS and further 
processed using a ChIP-IT High Sensitivity kit (Active Motive). 5 × 
106 PFA-fixed cells were used as a starting material. Indexed ChIP-
seq libraries were generated using NEBNext reagents (New England 
Biolabs, Inc.), and ChIP libraries were sequenced on the HiSeq 2500 
platform (Illumina), producing 30–70 million reads per library. Se-
quencing reads were aligned to the mm9 mouse genome assembly 
(University of California, Santa Cruz, Genome Browser). Specific 
areas of binding were identified with Sicer using default settings. For 
ChIP-qPCR, precipitated DNA was analyzed using primers designed 
for the promoter regions of Cbx4, Lor, Nefl, and Cdkn2a genes (Table 
S3). ChIP-qPCR data were pooled, means ± SD were calculated, and 
statistical analysis was performed using a one-way ANO VA test as 
described previously (Mardaryev et al., 2011).
Embryonic tissue culture
Whole dorsal skin culture from E13.5 p63+/− embryos were prepared 
and maintained as previously described (Botchkarev et al., 1999). In 
brief, skin samples were dissected from embryos and cultured in the 
6-well plates containing Williams’ medium E. Within 2 h after the cul-
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ture preparation, tissue samples were infected with p63 shRNA lentivi-
rus in combination with either Cbx4-expressing or control lentiviruses 
and the addition of 10 µg/ml polybrene (Sigma-Aldrich) for 48 h. The 
tissue was frozen and embedded into optimal cutting temperature me-
dium for subsequent immunofluorescent and qRT-PCR analyses.
Online supplemental material
Fig. S1 shows expression of the PRC1/PRC2 and Nefl genes in mouse 
epidermis during development. Fig. S2 shows characterization of the 
changes in gene expression in the epidermis of Cbx4KO mice and in 
primary KCs after Cbx4 knockdown. Fig. S3 shows analyses of the 
senescence and apoptotic markers in WT and Cbx4-deficient skin. Fig. 
S4 shows the details of the epidermal and Merkel cell differentiation 
in Cbx4KO and WT mice. Table S1 shows expression of the PRC1 
and PRC2 genes in epidermal KCs at different stages of epidermal 
development. Table S2 shows Cbx4 target genes up-regulated in the 
skin epithelium of p63KO mice. Tables S3 and S4 present a list of 
primers used for qRT-PCR analyses and a list of antibodies used in 
this study, respectively. Table S5 shows Cbx4 target genes in epidermal 
KCs. Online supplemental material is available at http ://www .jcb .org /
cgi /content /full /jcb .201506065 /DC1.
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